Proteostasis Ther (PTI) Stock Price & Overview

NYSE:PTI

Current stock price

1.11
-0.04 (-3.48%)
At close:
1.1
-0.01 (-0.9%)
After Hours:

The current stock price of PTI is 1.11 null. Today PTI is down by -3.48%. In the past month the price increased by 8.82%. In the past year, price decreased by -50.22%.

PTI Key Statistics

52-Week Range0.87 - 2.39
Current PTI stock price positioned within its 52-week range.
1-Month Range0.98 - 1.31
Current PTI stock price positioned within its 1-month range.
Market Cap
57.925M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.75
Dividend Yield
N/A

PTI Stock Performance

Today
-3.48%
1 Week
-5.93%
1 Month
+8.82%
3 Months
-0.89%
Longer-term
6 Months -21.28%
1 Year -50.22%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

PTI Stock Chart

Proteostasis Ther / PTI Daily stock chart

PTI Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to PTI. When comparing the yearly performance of all stocks, PTI is a bad performer in the overall market: 96% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

PTI Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to PTI. PTI has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PTI Earnings

Next Earnings DateN/A
Last Earnings DateN/A

PTI Forecast & Estimates


Analysts
Analysts100
Price TargetN/A
EPS Next Y39.66%
Revenue Next YearN/A

PTI Financial Highlights

Over the last trailing twelve months PTI reported a non-GAAP Earnings per Share(EPS) of -0.75. The EPS increased by 41.41% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-38.80M
Industry RankSector Rank
PM (TTM) N/A
ROA -71.38%
ROE N/A
Debt/Equity 0.31
Chartmill High Growth Momentum
EPS Q2Q%36%
Sales Q2Q%N/A
EPS 1Y (TTM)41.41%
Revenue 1Y (TTM)-100%

PTI Ownership

Ownership
Inst Owners15.65%
Shares52.19M
Float36.18M
Ins Owners19.48%
Short Float %N/A
Short RatioN/A

About PTI

Company Profile

Proteostasis Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics to treat diseases caused by an imbalance in the proteostasis network primarily in the United States. Proteostasis Therapeutics, Inc. is based in Cambridge, Massachusetts.

Company Info

Proteostasis Ther

80 Guest Street Suite 500

Boston MA 02135

CEO: Meenu Chhabra

Phone: 617-225-0096

Proteostasis Ther / PTI FAQ

What does PTI do?

Proteostasis Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics to treat diseases caused by an imbalance in the proteostasis network primarily in the United States. Proteostasis Therapeutics, Inc. is based in Cambridge, Massachusetts.


What is the stock price of Proteostasis Ther today?

The current stock price of PTI is 1.11 null. The price decreased by -3.48% in the last trading session.


Does PTI stock pay dividends?

PTI does not pay a dividend.


How is the ChartMill rating for Proteostasis Ther?

PTI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Would investing in Proteostasis Ther be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PTI.